Imbria Pharmaceuticals

📍 Boston, United States🗓 Founded 2018👥 17 employees
Biotechnology🌐 imbria.com
Website LinkedIn
Imbria Pharmaceuticals’ mission is to translate our understanding of cellular metabolism into innovative medicines that improve the lives of patients with limited or inadequate treatment options. The company was founded by doctors and launched by an all doctor executive team motivated by the promise of bringing new therapies to people in need. We are propelled by a deep scientific interest in cellular metabolism and the mitochondria, and are guided by both values and a code of business conduct built upon our commitment to always put the patients, families and communities we serve at the forefront of all that we do.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Imbria Pharmaceuticals founded?
Imbria Pharmaceuticals was founded in 2018.
What industry is Imbria Pharmaceuticals in?
Imbria Pharmaceuticals operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Imbria Pharmaceuticals based?
Imbria Pharmaceuticals is headquartered in Boston, United States.